190 related articles for article (PubMed ID: 37479567)
21. Synthesis, biological evaluation and docking studies of trans-stilbene methylthio derivatives as cytochromes P450 family 1 inhibitors.
Wierzchowski M; Dutkiewicz Z; Gielara-Korzańska A; Korzański A; Teubert A; Teżyk A; Stefański T; Baer-Dubowska W; Mikstacka R
Chem Biol Drug Des; 2017 Dec; 90(6):1226-1236. PubMed ID: 28632937
[TBL] [Abstract][Full Text] [Related]
22. Induction and localization of cytochrome P450 1B1 (CYP1B1) protein in the livers of TCDD-treated rats: detection using polyclonal antibodies raised to histidine-tagged fusion proteins produced and purified from bacteria.
Walker NJ; Crofts FG; Li Y; Lax SF; Hayes CL; Strickland PT; Lucier GW; Sutter TR
Carcinogenesis; 1998 Mar; 19(3):395-402. PubMed ID: 9525272
[TBL] [Abstract][Full Text] [Related]
23. Time-dependent transcriptional induction of CYP1A1, CYP1A2 and CYP1B1 mRNAs by H+/K+ -ATPase inhibitors and other xenobiotics.
Krusekopf S; Roots I; Hildebrandt AG; Kleeberg U
Xenobiotica; 2003 Feb; 33(2):107-18. PubMed ID: 12623754
[TBL] [Abstract][Full Text] [Related]
24. 7H-dibenzo[c,g]carbazole metabolism by the mouse and human CYP1 family of enzymes.
Shertzer HG; Genter MB; Talaska G; Curran CP; Nebert DW; Dalton TP
Carcinogenesis; 2007 Jun; 28(6):1371-8. PubMed ID: 17166882
[TBL] [Abstract][Full Text] [Related]
25. Nitidine Chloride-Induced CYP1 Enzyme Inhibition and Alteration of Estradiol Metabolism.
Mao X; Wang J; Wang Q; Yang L; Li Y; Lin H; Peng Y; Zheng J
Drug Metab Dispos; 2019 Aug; 47(8):919-927. PubMed ID: 31147316
[TBL] [Abstract][Full Text] [Related]
26. Enzymatic characterization of in vitro-expressed Baikal seal cytochrome P450 (CYP) 1A1, 1A2, and 1B1: implication of low metabolic potential of CYP1A2 uniquely evolved in aquatic mammals.
Iwata H; Yamaguchi K; Takeshita Y; Kubota A; Hirakawa S; Isobe T; Hirano M; Kim EY
Aquat Toxicol; 2015 May; 162():138-151. PubMed ID: 25814058
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the dose-response of CYP1B1, CYP1A1, and CYP1A2 in the liver of female Sprague-Dawley rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Walker NJ; Portier CJ; Lax SF; Crofts FG; Li Y; Lucier GW; Sutter TR
Toxicol Appl Pharmacol; 1999 Feb; 154(3):279-86. PubMed ID: 9931287
[TBL] [Abstract][Full Text] [Related]
28. The Effect of Oxidation on Berberine-Mediated CYP1 Inhibition: Oxidation Behavior and Metabolite-Mediated Inhibition.
Lo SN; Shen CC; Chang CY; Tsai KC; Huang CC; Wu TS; Ueng YF
Drug Metab Dispos; 2015 Jul; 43(7):1100-7. PubMed ID: 25953522
[TBL] [Abstract][Full Text] [Related]
29. Effect of Ginkgo biloba extract on procarcinogen-bioactivating human CYP1 enzymes: identification of isorhamnetin, kaempferol, and quercetin as potent inhibitors of CYP1B1.
Chang TK; Chen J; Yeung EY
Toxicol Appl Pharmacol; 2006 May; 213(1):18-26. PubMed ID: 16226778
[TBL] [Abstract][Full Text] [Related]
30. Organization of NADPH-cytochrome P450 reductase and CYP1A2 in the endoplasmic reticulum--microdomain localization affects monooxygenase function.
Brignac-Huber L; Reed JR; Backes WL
Mol Pharmacol; 2011 Mar; 79(3):549-57. PubMed ID: 21156755
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of aryl hydrocarbon receptor transactivation and DNA adduct formation by CYP1 isoform-selective metabolic deactivation of benzo[a]pyrene.
Endo K; Uno S; Seki T; Ariga T; Kusumi Y; Mitsumata M; Yamada S; Makishima M
Toxicol Appl Pharmacol; 2008 Jul; 230(2):135-43. PubMed ID: 18372000
[TBL] [Abstract][Full Text] [Related]
32. For dioxin-induced birth defects, mouse or human CYP1A2 in maternal liver protects whereas mouse CYP1A1 and CYP1B1 are inconsequential.
Dragin N; Dalton TP; Miller ML; Shertzer HG; Nebert DW
J Biol Chem; 2006 Jul; 281(27):18591-600. PubMed ID: 16636061
[TBL] [Abstract][Full Text] [Related]
33. Candidate cytochrome P450 genes for ethoxyresorufin O-deethylase activity in oyster Crassostrea gigas.
Siebert MN; Mattos JJ; Toledo-Silva G; Razzera G; Bainy ACD
Aquat Toxicol; 2017 Aug; 189():142-149. PubMed ID: 28623690
[TBL] [Abstract][Full Text] [Related]
34. Hydration and Structural Adaptations of the Human CYP1A1, CYP1A2, and CYP1B1 Active Sites by Molecular Dynamics Simulations.
Dutkiewicz Z; Mikstacka R
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511239
[TBL] [Abstract][Full Text] [Related]
35. Real-time polymerase chain reaction analysis of CYP1B1 gene expression in human liver.
Chang TK; Chen J; Pillay V; Ho JY; Bandiera SM
Toxicol Sci; 2003 Jan; 71(1):11-9. PubMed ID: 12520071
[TBL] [Abstract][Full Text] [Related]
36. Effects of histone deacetylation and DNA methylation on the constitutive and TCDD-inducible expressions of the human CYP1 family in MCF-7 and HeLa cells.
Nakajima M; Iwanari M; Yokoi T
Toxicol Lett; 2003 Sep; 144(2):247-56. PubMed ID: 12927368
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and evaluation of the inhibitory selectivity of novel trans-resveratrol analogues on human recombinant CYP1A1, CYP1A2 and CYP1B1.
Mikstacka R; Rimando AM; Dutkiewicz Z; Stefański T; Sobiak S
Bioorg Med Chem; 2012 Sep; 20(17):5117-26. PubMed ID: 22863525
[TBL] [Abstract][Full Text] [Related]
38. Characterization of differences in substrate specificity among CYP1A1, CYP1A2 and CYP1B1: an integrated approach employing molecular docking and molecular dynamics simulations.
Kesharwani SS; Nandekar PP; Pragyan P; Rathod V; Sangamwar AT
J Mol Recognit; 2016 Aug; 29(8):370-90. PubMed ID: 26916064
[TBL] [Abstract][Full Text] [Related]
39. Effects of xenobiotics on CYP1 enzyme-mediated biotransformation and bioactivation of estradiol.
Mao X; Li H; Zheng J
Drug Metab Rev; 2023; 55(1-2):1-49. PubMed ID: 36823774
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of CYP1 by berberine, palmatine, and jatrorrhizine: selectivity, kinetic characterization, and molecular modeling.
Lo SN; Chang YP; Tsai KC; Chang CY; Wu TS; Ueng YF
Toxicol Appl Pharmacol; 2013 Nov; 272(3):671-80. PubMed ID: 23886934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
